JENBURKT PHARMACEUTICALS
Back to Balance Sheet
|
JENBURKT PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-1.42 Cr | ₹-0.38 Cr | ₹-0.01 Cr | ₹0.29 Cr | ₹0.49 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of JENBURKT PHARMACEUTICALS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹-1.42 Cr |
| Mar2025 | ₹-0.38 Cr |
| Mar2024 | ₹-0.01 Cr |
| Mar2023 | ₹0.29 Cr |
| Mar2022 | ₹0.49 Cr |
How is Deferred Tax Assets / Liabilities of JENBURKT PHARMACEUTICALS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-1.42 Cr | Negative | |
| Mar2025 | ₹-0.38 Cr | Negative | |
| Mar2024 | ₹-0.01 Cr | Negative | |
| Mar2023 | ₹0.29 Cr | -39.59 | |
| Mar2022 | ₹0.49 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of JENBURKT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JENBURKT PHARMACEUTICALS | ₹499.7 Cr | 5.5% | 3.5% | -13% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,431.0 Cr | -2.3% | 3% | 12.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,115.0 Cr | 2.9% | 22.7% | 25.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,853.0 Cr | -2.7% | 2% | 33.9% | Stock Analytics | |
| CIPLA | ₹119,158.0 Cr | 0.1% | 3% | -7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | 2.4% | -12.9% | -9.1% | Stock Analytics | |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JENBURKT PHARMACEUTICALS | 5.5% |
3.5% |
-13% |
| SENSEX | 1.3% |
1% |
-2.9% |
You may also like the below Video Courses